Home › Funds › CULLINAN ASSOCIATES INC › CME

CULLINAN ASSOCIATES INC position in CME

CME GROUP INC · Financials

CULLINAN ASSOCIATES INC reported holding 26,902 shares of CME (CME GROUP INC) in its Q3 2026 13F filing — a position valued at US$7.0M, representing 0.53% of its reported portfolio and ranking #48 among its reported holdings. CULLINAN ASSOCIATES INC has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)26.90K sh
Reported value held$7.05M
Portfolio Weight0.53%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CULLINAN ASSOCIATES INC's CME position evolved

CULLINAN ASSOCIATES INC first disclosed a stake in CME in Q3 2023 at 4,240 shares (US$849K). The position peaked in Q4 2025 at 38,753 shares, worth US$10.6M. Across 13 filings, CULLINAN ASSOCIATES INC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 26,902 shares valued at US$7.0M — a reduction of -995 shares quarter over quarter.. Notable position changes include a 36% trim in Q3 2024 (shares rose 5% over the following quarter), a 614% increase in Q4 2024 (shares rose 14% over the following quarter), a 83% increase in Q3 2025 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.24K $848.93K New
Q4 2023 3.84K $808.70K Reduce
Q1 2024 3.83K $824.56K Hold
Q2 2024 3.83K $752.98K Hold
Q3 2024 2.47K $561.36K Reduce
Q4 2024 17.65K $4.10M Add
Q1 2025 18.95K $5.03M Add
Q2 2025 19.40K $5.35M Add
Q3 2025 35.45K $9.58M Add
Q4 2025 38.75K $10.58M Add
Q1 2026 30.69K $9.06M Reduce
Q2 2026 27.90K $6.16M Reduce
Q3 2026 26.90K $7.05M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CME and 13F data

CME (CME GROUP INC) is a Financials company. 25 other funds we track also report a position in CME — the largest reported positions include Sanders Capital, LLC (US$1.33B), RAYMOND JAMES FINANCIAL INC (US$1.08B), Fidelity International (FIL) (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CME

All CME fund holders →

FAQ

How long has CULLINAN ASSOCIATES INC held CME?

CULLINAN ASSOCIATES INC has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CULLINAN ASSOCIATES INC's current position in CME?

As of Q3 2026, CULLINAN ASSOCIATES INC holds 26.90K shares of CME (CME GROUP INC), valued at $7.05M, representing 0.53% of its reported portfolio and ranking #48.

Has CULLINAN ASSOCIATES INC been buying or selling CME?

In the latest 13F filing (Q3 2026), CULLINAN ASSOCIATES INC reduced its position in CME. The position peaked in Q4 2025 at 38.75K shares.

Which other funds hold CME?

Other major institutional holders of CME include Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, Fidelity International (FIL), among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.